Moll Thomas 4
4 · Adamis Pharmaceuticals Corp · Filed Mar 12, 2013
Insider Transaction Report
Form 4
Moll Thomas
Vice President of Research
Transactions
- Award
Common Stock
2013-03-06+39,140→ 374,110 total - Award
Common Stock
2013-03-06+55,970→ 334,970 total - Award
Employee Stock Option (right to buy)
2013-03-06+187,594→ 187,594 totalExercise: $0.67Exp: 2023-03-06→ Common Stock (187,594 underlying)
Footnotes (3)
- [F1]The shares being reported are being issued pursuant to restricted stock units, each one of which represents a contingent right to receive one share of the issuer's common stock. All of the restricted stock units vest on March 6, 2014.
- [F2]The shares being reported are being issued pursuant to restricted stock units, each one of which represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in equal annual installments over three years.
- [F3]The option vests and becomes exercisable as to 1/36 of the option shares on each monthly anniversary of the grant date